Kheiron scores $22 mln Series A

Kheiron Medical Technologies, an applied science company focused on supporting cancer diagnostics with machine learning, has raised $22 million in Series A funding. Atomico led the round with participation from Connect Ventures, Greycroft, Hoxton Ventures and EXOR Seeds. As part of this investment, Atomico Principal Irina Haivas will join Kheiron’s board.

Source: Press Release